|
|
|
| 【主 题】 ： |
Dalbavancin |
| 【联系人名】 ： |
Caroline Miller |
| 【电子邮件】 ： |
contact@creative-peptides.com |
| 【联系电话】 ： |
15166698109 |
| 【发布日期】 ： |
2016-9-6 |
| 【详细说明】 ： |
Dalbavancin (INN, trade name Dalvance) is a novel
second-generation lipoglycopeptide antibiotic. It
belongs to the same class as vancomycin.The Food and
Drug Administration approved dalbavancin for the
treatment of acute bacterial skin and skin structure
infections caused by certain susceptible bacteria. More
information please visit the website:
http://www.creative-peptides.com/product/dalbavancin-
item-10-101-78-32.html
|
|
|
|
|
English
